Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Alphora is pleased to announce that it has added GMP ICP/MS Heavy Metals Testing in-house, to align with the increased regulatory requirements of USP <232> & <233>, which became effective February 1, 2013. API Drug Substances, Drug Products and Excipients will...
read more
Wednesday, November 18, 2015
Alphora is pleased to announce the completion of a new 3,000 sq. ft. analytical laboratory expansion.
read more
Alphora is pleased to announce that it has completed $2M in capital investments, adding two Flow Chemistry platforms
and additional process chemistry and analytical technologies to its toolbox. These additions represent a significant
investment for...
read more
Monday, September 12, 2016
Alphora is pleased to announce its decision to expand plant operations with an $8M capital investment. The expansion will double the size of the plant operations, adding additional 500L, 200L and 50L vessels. The new plant is expected to be fully ...
read more
Wednesday, September 16, 2015
The ALS Association announced that a critical effort made possible by the ALS Ice Bucket Challenge is underway, involving nearly 100 people with ALS and caregivers, researchers, clinicians, and industry experts from across the country to create drug ...
read more
Friday, February 28, 2020
Altasciences has acquired Alliance Contract Pharma.
read more
Wednesday, January 05, 2022
Altasciences, an integrated CRO/CDMO has completed the acquisition of Sinclair Research, a preclinical CRO located in the Midwest. Complementing existing locations on the East and West Coast, the new site will facilitate even greater access to ...
read more
Wednesday, August 07, 2019
Altasciences announced Dr. Beatrice Setnik, Ph.D. as Chief Scientific Officer, supporting internal and external clients.
read more
Altasciences has announced the appointment of Dr. Joseph A. Francisco as Chief Toxicologist.
read more
Tuesday, February 12, 2019
Altasciences unveiled a new brand identity and website.
read more
Altasciences announced the addition of Paul Sidney to their Compliance and Regulatory Affairs team as Senior Director.
read more
Wednesday, September 04, 2019
Altasciences announced the addition of Dr. Lynne LeSauteur, PhD, to their bioanalytical management team, responsible for the Bioanalytical Services department in the US and the Ligand Binding team in Canada.
read more
Wednesday, November 01, 2023
Altasciences announced the completion of its newly expanded, 8,000-square-foot space, which includes a test material department, features state-of-the-art equipment and forty-eight workbenches, with a vast range of services, including ligand binding ...
read more
Thursday, September 30, 2021
Altasciences announced the continued expansion of their formulation, manufacturing, and analytical services facilities in Philadelphia, PA. Altasciences, an integrated drug development solution company offering pharmaceutical and biotechnology ...
read more
Wednesday, November 24, 2021
Altasciences, a drug development solution company, announced the completion of a second expansion of their ligand binding laboratory to meet the high demand for quality bioanalytical services.
read more